Percutaneous catheter directed intravascular occlusion device

US9743918B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9743918-B2
Application numberUS-23505908-A
CountryUS
Kind codeB2
Filing dateSep 22, 2008
Priority dateJan 18, 2008
Publication dateAug 29, 2017
Grant dateAug 29, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments of the present invention provide medical devices and methods for occluding a target site are provided. For example, the medical device may include a tubular member having proximal and distal ends and at least one plane of occlusion. The at least one plane of occlusion may be configured to substantially occlude the patent ductus arteriosus in less than about 1 minute. In addition or alternatively, the tubular member may consist of a single layer of material and be configured to be constrained within a catheter having an outer diameter of less than about 4 French for percutaneous delivery to the patent ductus arteriosus.

First claim

Opening claim text (preview).

That which is claimed: 1. A medical device for occluding a patent ductus arteriosus between an aorta and a pulmonary artery, the medical device comprising: only one layer of braided fabric; wherein the only one layer of braided fabric forms a tubular member having proximal and distal ends; wherein the tubular member comprises a proximal disk-shaped portion at the proximal end and a distal disk-shaped portion at the distal end and a geometrical-shaped portion disposed therebetween, each of the proximal and distal disk-shaped portions having a maximum cross-sectional dimension larger than the geometrical shaped portion, the proximal disk-shaped portion having a maximum diameter at a distal end thereof and the distal disk-shaped portion having a maximum diameter at a proximal end thereof; wherein the tubular member further comprises a transition segment coupled to either of the proximal or distal disk-shaped portions and the geometrical-shaped portion, the transition segment having a maximum cross-sectional dimension smaller than both the proximal and distal disk-shaped portions and the geometrical shaped portion, wherein each of the proximal disk-shaped portion maximum diameter and the distal disk-shaped portion maximum diameter extend inwardly to overlap the respective transition segment; and wherein the only one layer of braided fabric is configured to be constrained within a catheter having an outer diameter of about 5 French or smaller for percutaneous delivery to the patent ductus arteriosus. 2. The medical device of claim 1 , further comprising a pair of transition segments, each transition segment coupled to one of the proximal or distal disk-shaped portions and the geometrical shaped portion and having a maximum cross-sectional dimension smaller than both the proximal and distal disk-shaped portions and the geometrical shaped portion. 3. The medical device of claim 1 , wherein the only one layer of braided fabric comprises a plurality of braided metal strands. 4. The medical device of claim 3 , wherein the metal strands comprise a material selected from the group consisting of stainless steel, nickel based, cobalt based, nickel-titanium, shape memory, and super-elastic materials. 5. The medical device of claim 1 , wherein the tubular member is configured to be constrained within a catheter having an outer diameter of about 4 French or smaller for percutaneous delivery. 6. The medical device of claim 1 , wherein the tubular member comprises at least one plane of occlusion configured to substantially occlude the patent ductus arteriosus in less than or equal to 1 minute from the time the tubular member is deployed in the patent ductus arteriosus to a time wherein contrast media injected on one side of the tubular member in the aorta does not flow through the tubular member to the other side of the tubular member in the pulmonary artery. 7. A delivery system for delivering a medical device for occluding a patent ductus arteriosus, the delivery system comprising: a delivery device coupled to the medical device according to claim 1 ; and a catheter configured to overlie the delivery device and constrain the medical device therein, wherein the medical device is configured to be deployed from the catheter, and wherein the delivery device and catheter are configured to be delivered bi-directionally to the patent ductus arteriosus either transarterially or transvenously and to deploy the medical device at least partially within the patent ductus arteriosus. 8. The delivery system of claim 7 , wherein the medical device comprises a plurality of planes of occlusion configured to be positioned outside of the patent ductus arteriosus and a plurality of planes of occlusion configured to be positioned within a cavity defined by the patent ductus arteriosus. 9. The delivery system of claim 7 , wherein the catheter has an outer diameter of about 5 French. 10. The delivery system of claim 7 , wherein the catheter has an outer diameter of about 4 French or smaller. 11. The delivery system of claim 7 , wherein the delivery device and catheter are configured to be delivered to the patent ductus arteriosus over a guidewire. 12. The delivery system of claim 7 , wherein the catheter is axially displaceable relative to the delivery device such that the medical device is configured to be deployed from the catheter in response to displacement of the catheter with respect to the delivery device. 13. A method for occluding a patent ductus arteriosus, the method comprising: providing a medical device according to claim 1 ; constraining the medical device from a preset expanded configuration to a reduced configuration; positioning the constrained medical device in a catheter, the catheter and device configured to be delivered bi-directionally, either transarterially or transvenously; delivering the medical device to the patent ductus arteriosus either transarterially or transvenously; and deploying the medical device from the catheter at least partially within the patent ductus arteriosus such that the tubular member returns to the preset expanded configuration. 14. The method of claim 13 , wherein the medical device comprises a plurality of planes of occlusion, and wherein deploying comprises deploying the medical device such that at least one plane of occlusion is positioned outside the patent ductus arteriosus and at least one plane of occlusion is positioned within a cavity defined within the patent ductus arteriosus. 15. The method of claim 13 , wherein deploying comprises detaching a delivery system positioned within the catheter and coupled to the medical device. 16. The method of claim 13 , wherein delivering comprises delivering the medical device over a guide wire. 17. The method of claim 13 , further comprising imaging the patent ductus arteriosus using at least one of two-dimensional intracardiac echocardiography, angiography, magnetic resonance imaging, transesphogeal echocardiograpy, or Doppler color flow mapping. 18. The method of claim 13 , further comprising verifying occlusion of the patent ductus arteriosus by injecting a radiopaque contrast media through the catheter and into the aorta downstream of the deployed medical device and observing with angiography whether contrast enters the cavity defined by the patent ductus arteriosus and further whether any contrast within the cavity is stagnant.

Assignees

Inventors

Classifications

  • Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening · CPC title

  • for closure at remote site, e.g. closing atrial septum defects · CPC title

  • Elastic or resilient implements · CPC title

  • Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect (sutures A61B17/04; closing rectum or urethra near body surface A61F2/0009) · CPC title

  • for fields applied by a magnetic resonance imaging system · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9743918B2 cover?
Embodiments of the present invention provide medical devices and methods for occluding a target site are provided. For example, the medical device may include a tubular member having proximal and distal ends and at least one plane of occlusion. The at least one plane of occlusion may be configured to substantially occlude the patent ductus arteriosus in less than about 1 minute. In addition or …
Who is the assignee on this patent?
Amplatz Kurt, Gu Xiaoping, Oslund John C, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61B17/0057. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).